Cargando…

The Addition of EGFR Inhibitors in Neoadjuvant Therapy for KRAS-Wild Type Locally Advanced Rectal Cancer Patients: A Systematic Review and Meta-Analysis

BACKGROUND: Patients with locally advanced rectal cancer (LARC) are at higher risk of local and distant recurrence and are thus more vulnerable to metastatic diseases. Neoadjuvant chemoradiotherapy (nCRT) and subsequent curative resection with total mesorectal excision (TME) followed by adjuvant che...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Xi, Zhou, Yue, Cui, Wanbin, Su, Xin, Guo, Zhexu, Hidasa, Iko, Li, Qincai, Wang, Zhenning, Song, Yongxi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242658/ https://www.ncbi.nlm.nih.gov/pubmed/32499700 http://dx.doi.org/10.3389/fphar.2020.00706

Ejemplares similares

The efficacy and safety of adding bevacizumab in neoadjuvant therapy for locally advanced rectal cancer patients: A systematic review and meta-analysis
por: Zhou, Yue, et al.
Publicado: (2020)

The efficacy of adding targeted agents to neoadjuvant therapy for locally advanced rectal cancer patients: a meta‐analysis
por: Zhong, Xi, et al.
Publicado: (2018)

EGFR and KRAS Mutations in Lung Parenchyma of Subjects With EGFR/KRAS Wild-Type Lung Adenocarcinoma
por: Chalela, Roberto, et al.
Publicado: (2021)

Statin use and its potential therapeutic role in esophageal cancer: a systematic review and meta-analysis
por: Zhou, Cen, et al.
Publicado: (2019)

Prognostic Biomarkers for Gastric Cancer: An Umbrella Review of the Evidence
por: Zhou, Cen, et al.
Publicado: (2019)

The Potential Effect of Metformin on Cancer: An Umbrella Review
por: Yu, Hong, et al.
Publicado: (2019)

Aspirin and Its Potential Preventive Role in Cancer: An Umbrella Review
por: Song, Yongxi, et al.
Publicado: (2020)

The long noncoding RNA CTA‐941F9.9 is frequently downregulated and may serve as a biomarker for carcinogenesis in colorectal cancer
por: Guo, Zhexu, et al.
Publicado: (2019)

SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy
por: De Mattia, Elena, et al.
Publicado: (2021)

Efficacy and safety of neoadjuvant imatinib therapy for patients with locally advanced rectal gastrointestinal stromal tumors: A multi-center cohort study
por: Li, Weihao, et al.
Publicado: (2022)

Survival Prediction of Patients Treated With Immune Checkpoint Inhibitors via KRAS/TP53/EGFR-Single Gene Mutation
por: Liu, Shui, et al.
Publicado: (2022)

Timing of additional neoadjuvant chemotherapy in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and total mesorectal excision
por: He, Fang, et al.
Publicado: (2022)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
por: Lin, Huaqin, et al.
Publicado: (2021)

Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy
por: Bengala, C, et al.
Publicado: (2010)

Natural product manoalide promotes EGFR-TKI sensitivity of lung cancer cells by KRAS-ERK pathway and mitochondrial Ca(2+) overload-induced ferroptosis
por: Ni, Yinyun, et al.
Publicado: (2023)

Neoadjuvant targeted therapy for resectable EGFR-mutant non-small cell lung cancer: Current status and future considerations
por: Liu, Wenliang, et al.
Publicado: (2022)

Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
por: Papaccio, Federica, et al.
Publicado: (2020)

Regulation of IFN-γ-mediated PD-L1 expression by MYC in colorectal cancer with wild-type KRAS and TP53 and its clinical implications
por: Guo, Libin, et al.
Publicado: (2022)

COL1A1: A potential therapeutic target for colorectal cancer expressing wild-type or mutant KRAS
por: Zhang, Zheying, et al.
Publicado: (2018)

Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery
por: Derbel, Olfa, et al.
Publicado: (2013)

Effects of methylenetetrahydrofolate reductase single-nucleotide polymorphisms on breast, cervical, ovarian, and endometrial cancer susceptibilities
por: Wang, Zheng, et al.
Publicado: (2021)

Total neoadjuvant treatment in locally advanced rectal cancer
por: De Felice, Francesca, et al.
Publicado: (2021)

Combined Analysis of EGFR and PTEN Status in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
por: Chen, Yu, et al.
Publicado: (2015)

Conversion Surgery for Stage IV Gastric Cancer
por: Zhang, Fei, et al.
Publicado: (2019)

Positive lymph node ratio is an index in predicting prognosis for remnant gastric cancer with insufficient retrieved lymph node in R0 resection
por: Wang, Honghu, et al.
Publicado: (2021)

Current Approaches for Predicting a Lack of Response to Anti-EGFR Therapy in KRAS Wild-Type Patients
por: Er, Tze-Kiong, et al.
Publicado: (2014)

First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis
por: Ottaiano, Alessandro, et al.
Publicado: (2018)

Hedgehog Suppresses Paclitaxel Sensitivity by Regulating Akt-Mediated Phosphorylation of Bax in EGFR Wild-Type Non-Small Cell Lung Cancer Cells
por: Tu, Yun-Chieh, et al.
Publicado: (2022)

A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: Li, Yi, et al.
Publicado: (2016)

Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Kawai, Kazushige, et al.
Publicado: (2018)

Honokiol Induces Apoptosis, G1 Arrest, and Autophagy in KRAS Mutant Lung Cancer Cells
por: Luo, Lian-Xiang, et al.
Publicado: (2017)

CRIP1 Reshapes the Gastric Cancer Microenvironment to Facilitate Development of Lymphatic Metastasis
por: Wu, Zhonghua, et al.
Publicado: (2023)

Lymph node regression grading of locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
por: He, Lei, et al.
Publicado: (2022)

Tumor deposits: markers of poor prognosis in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy
por: Zhang, Lu-Ning, et al.
Publicado: (2015)

KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
por: Sclafani, Francesco, et al.
Publicado: (2018)

Case Report: Chemotherapy-free treatment with camrelizumab and anlotinib for elderly patients with KRAS and TP53 mutated advanced lung cancer
por: Qi, Wenbo, et al.
Publicado: (2023)

Impact of the distal resection margin on local recurrence after neoadjuvant chemoradiation and rectal excision for locally advanced rectal cancer
por: Song, Seung Ho, et al.
Publicado: (2021)

Pathological complete response in MMR-deficient/MSI-high and KRAS-mutant patient with locally advanced rectal cancer after neoadjuvant chemoradiation with immunotherapy: A case report
por: Zhang, Mai, et al.
Publicado: (2022)

Long-Term Survival in Locally Advanced KRAS Wild-Type Pancreatic Adenocarcinoma
por: Alhenc-Gelas, Marion, et al.
Publicado: (2019)

Laparoscopic intersphincteric resection versus an open approach for low rectal cancer: a meta-analysis
por: Chen, Hanyu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u7bhv1brdhfuqs2ne5ujdf622u